ESR1 and breast cancer: CLN3 overexpression did not correlate with lower or higher tumor grade, age, menopausal status, ER, PR, and HER2 expression, when comparing the level of CLN3 mRNA between breast cancer and the surrounding non-tumor tissue (Table 1).